Status:

RECRUITING

Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy

Lead Sponsor:

City of Hope Medical Center

Collaborating Sponsors:

United States Department of Defense

Conditions:

Hematologic Malignancies

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Patient Inclusion Criteria Informed Consent and Willingness to Participate
  • Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
  • Age ≥ 18 years old at the time of enrollment
  • Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
  • Relapsed or refractory hematologic malignancy
  • Scheduled to receive outpatient standard of care (SOC) CAR-T therapy
  • Has a FCG committed to living with the patient for the duration of the study
  • Family Caregiver Inclusion Criteria Informed Consent and Willingness to Participate
  • Documented informed consent of the participant and/or legally authorized representative Age and Language Criteria
  • Age ≥ 18 years old at the time of enrollment
  • Ability to read and understand English or Spanish for Questionnaires Nature of Illness and Treatment Related Criteria
  • Family member or friend identified by the patient and defined as a person who knows the patient well and is involved in the patient's medical care
  • Exclusion Criteria 1. An employee who is under the direct/indirect supervision of the PI/ a co-investigator/ the study manager 2. A direct study team member
  • \-

Exclusion

    Key Trial Info

    Start Date :

    December 15 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 29 2029

    Estimated Enrollment :

    190 Patients enrolled

    Trial Details

    Trial ID

    NCT07186192

    Start Date

    December 15 2025

    End Date

    March 29 2029

    Last Update

    October 29 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    City of Hope Medical Center

    Duarte, California, United States, 91010